Chronic obstructive pulmonary disease (COPD): influence of clinic-anamnestic, anthropometric and functional characteristics on serum α-1-anitrypsin (AAT) in stable patients.
DOI:
https://doi.org/10.26641/2307-0404.2018.3(part1).142334Keywords:
COPD, exacerbation, α-1-antitrypsinAbstract
Aim of the study – to enhance the diagnostic and treatment tactics of stable COPD patients management at out patient stage by studying the serum AAT. Data of 45 outpatients with COPD (GOLD I-IV) and 20 healthy persons were included into analysis. Sex, age, height, weight, body mass index (BMI), smoking status were assessed. Lung function and serum AAT were measured. These results suggest that sex, age, height, weight, BMI do not influence on serum AAT both in stable COPD patients and healthy persons. Serum AAT statistically significant negatively correlate with airways obstruction degree in stable COPD patients. Significant moderate negative correlation between serum AAT and number of exacerbation during last year was found in stable COPD patients. This finding allows to suggest that serum AAT could be used as an indicator for COPD prognosis.
References
Averyanov AV. [The role of neutrophil elastase in the pathogenesis of chronic obstructive pulmonary disease]. Tsitokinyi i vospalenie. 2007;4:3-8. Russian.
Kovalenko OM, RodIonova VV, Voronina NO. [Features of thrombocyte linkage of hemostasis in patients with chronic obstructive pulmonary disease in combination with hypertension]. Medicni perspektivi. 2017;3:28-33. Ukainian.
Kononovich OS, Plehanova OV, Dmytrychenko VV, Bratus EV. [Infectious exacerbation of chronic obstructive pulmonary disease: features of the spectrum of pathogens in the Pridneprovia region] Ukr. pulmonol. zhurn. 2008;3:181-182. Russian.
Lapach CN, Gubenko AV, Babich PN. [Statistical methods in biomedical research using Excel]. Kyiv, Morion. 2000;320. Russian.
Mostovoy YuM, Demchuk AV. [COPD. Systemic effects and their prevention]. Ukr. pulmonol. zhurn. 2011;2:22-23. Russian.
Ostrovskiy MM, Gerich PR. [On the issue of polymorbidity and comorbidity in patients with COPD]. Ukr. pulmonol. zhurn. 2011;4:19-24. Ukainian.
Pertseva TA, Liholat EA, Gurzhiy EV. [Assessment of mucociliary clearance in patients with chronic obstructive pulmonary disease]. Ukr. pulmonol. zhurn. 2007;3:16-18. Russian.
Pertseva TA, Konopkina LI, Boguslavskaya EV. [Assessment of the functional state of respiratory muscles in patients with chronic obstructive pulmonary diseases in the formation of individual rehabilitation programs]. Ukr. pulmonol. zhurn. 2004;3:31-32. Russian.
Pertseva TO, Fesenko OV. [Peculiarities of the course of violations of cardiac rhythm and conduction in patients with a combination of coronary heart disease, arterial hypertension and chronic obstructive pulmonary disease]. Medicni perspektivi. 2009;XIV(3):28-33. Ukrainian.
Pertseva TO, Gashynova KYu, Viklienko YuI. [α1-antitrypsin (AAT) level in patients with chronic obstructive pulmonary disease]. Medicni perspektivi. 2011;XVI(2):98-104. Ukainian.
Pertseva TO, Gashynova KYu, Viklienko YuI. [COPD: α1-antitrypsin (AAT) level and exacerbation frequency]. Medicni perspektivi. 2011;XVI(4):21-24. Ukainian.
[On approval and implementation of medical-technological documents on standardization of medical care in chronic obstructive pulmonary disease: Order of the Ministry of Health of Ukraine No. 555 dated June 27, 2013]. Kyiv, Official publication. 2013;3. Ukainian.
Rebrova OYu. [Statistical analysis of medical data. Application of the STATISTICA application package]. Moskva, Mediasphera. 2002;312. Russian.
Vida R et al. [Recommendations for the diagnosis and management of patients with a deficiency of α1-antitrypsin in the Spanish Society of Pulmonology and Thoracic Surgery]. Pulmonologia. 2008;1:14-28. Russian.
Feschenko YuI. [COPD in Ukraine: problems and solutions]. Zdorov’ya Ukrainy. 27.03.2015. Available from: http://health-ua.com/article/3876.html. Russian.
Chapman H, Shi G. Protease Injury in the Development of COPD. Chest. 2000;117(5):295S-8S.
DeMeo D. Alpha1-Antitrypsin deficiency: Genetic aspects of Alpha1-antitrypsin deficiency: phenotypes and genetic modifiers of emphysema risk. Thorax. 2004;59(3):259-64.
Global Initiative for Chronic Obstructive Lung Diseases (GOLD). Global strategy for diagnosis, management, and prevention of chronic obstructive pulmonary disease. [Internet]. Updated 2016. Available from: http://goldcopd.org/global-strategy-diagnosis-management-prevention-copd-2016.
Global Initiative for Chronic Obstructive Lung Diseases (GOLD). Global strategy for diagnosis, management, and prevention of chronic obstructive pulmonary disease. [Internet]. Revised; 2011. Available from: http://www.goldcopd.org/uploads/users/files/GOLD_Report_2011_Feb21.pdf.
Global Initiative for Chronic Obstructive Lung Diseases (GOLD). Global strategy for diagnosis, management, and prevention of chronic obstructive pulmonary disease. [Internet]. GOLD; 2013. Available from: http://www.goldcopd.it/gruppi_lavoro/2013/GOLD%20EXECUTIVE%20SUMMARY.pdf.
Laurell C, Eriksson S. The Electrophoretic α;1-Globulin Pattern of Serum in α;1-Antitrypsin Deficiency. Scandinavian Journal of Clinical and Laboratory Investigation. 1963;15(2):132-40.
Stoller J. Clinical Features and Natural History of Severe α1-Antitrypsin Deficiency. Chest. 1997;111(6):123-8.
Survival and FEV1Decline in Individuals with Severe Deficiency of α1-Antitrypsin. American Journal of Respiratory and Critical Care Medicine. 1998;158(1):49-59.
Vidal R. American Thoracic Society/European Respiratory Society Statement. American Journal of Respiratory and Critical Care Medicine. 2003;168(7):818-900.
Downloads
How to Cite
Issue
Section
License
Copyright (c) 2018 Medicni perspektivi (Medical perspectives)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submitting manuscript to the journal "Medicni perspektivi" the author(s) agree with transferring copyright from the author(s) to publisher (including photos, figures, tables, etc.) editor, reproducing materials of the manuscript in the journal, Internet, translation into other languages, export and import of the issue with the author’s article, spreading without limitation of their period of validity both on the territory of Ukraine and other countries. This and other mutual duties of the author and all co-authors separately and editorial board are secured by written agreement by special form to use the article, the sample of which is presented on the site.
Author signs a written agreement and sends it to Editorial Board simultaneously with submission of the manuscript.
